No Data
No Data
Kanghui Pharmaceutical (603139.SH): Net profit of 1.086 million yuan in the first quarter decreased by 86.76% year on year
On April 26, Ge Longhui Pharmaceutical (603139.SH) released its first quarter report. Operating revenue was 127 million yuan, up 2.89% year on year, and net profit was 1.086 million yuan, down 86.76% year on year. After deducting non-net loss of 119 million yuan, basic earnings per share were 0.01 yuan.
A-share afternoon review: Shanghai index fell 0.52%, AI concept sector led the decline
The main A-share index opened low. As of the midday close, the Shanghai Index fell 0.52% to 3015.74 points, the Shenzhen Stock Exchange Index fell 1.25%, and the GEM index fell 1.46%.
Improved Revenues Required Before Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Stock's 33% Jump Looks Justified
Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) shareholders are no doubt pleased to see that the share price has bounced 33% in the last month, although it is still struggling to make up recen
Kanghui Pharmaceutical to Earn 151 Million Yuan From Kelavi Buyback
Shaanxi Kanghui Pharmaceutical (SHA:603139) will earn 151.2 million yuan after Hubei Kelavi Biopharmaceutical repurchases its shares from the Chinese drugmaker, according to a disclosure on the Shangh
Kanghui Pharmaceutical (603139.SH): Performance pledger plans to buy back 42.8725% of the company's shares in Clavey
On March 14, Ge Longhui Pharmaceuticals (603139.SH) announced that Hubei Clavey Biopharmaceutical Co., Ltd. (“Clavey”) plans to buy back 42.8725% of the company's shares in cash. The total transaction price for the company's investment in Clavey was RMB 119.98 million. After negotiations between the two parties, the repurchase pricing principle was “original investment amount+capital cost compensation for the period”. The total repurchase price was RMB 151.2069 million, of which the principal amount was RMB 119.98 million and interest was RMB 31.22,900 (interest rate was 10% annualized, and the interest period ended December 3, 2023
Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Not Doing Enough For Some Investors As Its Shares Slump 26%
Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) shareholders that were waiting for something to happen have been dealt a blow with a 26% share price drop in the last month. Instead of being
No Data